Norovirus

R&D and Collaboration

In recent years MBS has significantly increased its R&D facilities and assembled a dedicated team of R&D scientists whose only focus is to expand the antibody product line and add innovation to our custom services.

Click Here to See What’s New from MBS R&D

Collaboration Opportunities:

  • Leverage 20+ years of premier Hybridoma Development Experience at MBS with your expertise in the target of shared market interest
  • Generate a fair and mutually beneficial licensing agreement of the monoclonal antibody
  • Gain access to (or leverage) MBS network of contacts in biotechnology and diagnostic industries to sell antibody and generate revenue for your institution
  • Areas of collaborative interest
    • Infectious Disease
    • Veterinary Targets
    • Biomarkers
    • Food / Water Safety
    • Drug Development
    • Other

Contact Technical Marketing Analyst or Fill out our Application for Collaboration.